{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:26:22Z","timestamp":1761391582325,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,25]]},"DOI":"10.7759\/cureus.95377","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:18:32Z","timestamp":1761391112000},"source":"Crossref","is-referenced-by-count":0,"title":["Disseminated Pityriasis Versicolor Associated With Type 2 Diabetes Mellitus: A Clinical Case With Immunometabolic Insights"],"prefix":"10.7759","author":[{"given":"Jes\u00fas Iv\u00e1n","family":"Mart\u00ednez-Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Fern\u00e1ndez-Reyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra Nicole","family":"Macias Quiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/life13102097","article-title":"Pityriasis versicolor-a narrative review on the diagnosis and management","volume":"13","author":"\u0141ab\u0119d\u017a N","year":"2023","unstructured":"\u0141ab\u0119d\u017a N, Navarrete-Dechent C, Kubisiak-Rzepczyk H, Bowszyc-Dmochowska M, Pogorzelska-Antkowiak A, Pietkiewicz P. Pityriasis versicolor-a narrative review on the diagnosis and management. Life (Basel). 2023, 13:10.3390\/life13102097","journal-title":"Life (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2017.10.013","article-title":"Recurrent and disseminated pityriasis versicolor: a novel clinical form consequent to Malassezia-host interaction?","volume":"109","author":"Romero-Sandoval K","year":"2017","unstructured":"Romero-Sandoval K, Costa AA, Teixeira Sousa MG, et al.. Recurrent and disseminated pityriasis versicolor: a novel clinical form consequent to Malassezia-host interaction?. Med Hypotheses. 2017, 109:139-44. 10.1016\/j.mehy.2017.10.013","journal-title":"Med Hypotheses"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20164412","article-title":"Cutaneous fungal infections in subjects with diabetes mellitus","volume":"3","author":"Thilak S","year":"2017","unstructured":"Thilak S, Anbumalar M, Sneha PM. Cutaneous fungal infections in subjects with diabetes mellitus. Int J Res Dermatol. 2017, 3:55-8. 10.18203\/issn.2455-4529.IntJResDermatol20164412","journal-title":"Int J Res Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20164404","article-title":"A study of 200 cases of pityriasis versicolor: the distribution of age, gender, blood group, lesion morphology, hemoglobin levels, cholesterol levels and diabetic status","volume":"3","author":"Joshua J","year":"2017","unstructured":"Joshua J. A study of 200 cases of pityriasis versicolor: the distribution of age, gender, blood group, lesion morphology, hemoglobin levels, cholesterol levels and diabetic status.  Int J Res Dermatol. 2017, 3:20-4. 10.18203\/issn.2455-4529.IntJResDermatol20164404","journal-title":"Int J Res Dermatol"},{"key":"ref5","article-title":"Prevalence of pityriasis versicolor among diabetics in Basrah","volume":"4","author":"Mansour AA","year":"2008","unstructured":"Mansour AA, Hamdi KI, Al-Aseady AA. Prevalence of pityriasis versicolor among diabetics in Basrah. Arch Med Sci. 2008, 4:443-6.","journal-title":"Arch Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13775","article-title":"Factors associated with pityriasis versicolor in a large national database","volume":"67","author":"Hill RC","year":"2024","unstructured":"Hill RC, Faria W, Gold JA, Lipner SR. Factors associated with pityriasis versicolor in a large national database. Mycoses. 2024, 67:e13775. 10.1111\/myc.13775","journal-title":"Mycoses"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.09.052","article-title":"Pityriasis versicolor epidemiology, disease predictors, and health care utilization: analysis of 32,679 cases in a large commercial insurance database","volume":"92","author":"Gold JA","year":"2025","unstructured":"Gold JA, Benedict K, Lipner SR. Pityriasis versicolor epidemiology, disease predictors, and health care utilization: analysis of 32,679 cases in a large commercial insurance database. J Am Acad Dermatol. 2025, 92:316-9. 10.1016\/j.jaad.2024.09.052","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605644","article-title":"Skin immunity to dermatophytes: From experimental infection models to human disease","volume":"11","author":"Burstein VL","year":"2020","unstructured":"Burstein VL, Beccacece I, Guasconi L, Mena CJ, Cervi L, Chiapello LS. Skin immunity to dermatophytes: From experimental infection models to human disease. Front Immunol. 2020, 11:605644. 10.3389\/fimmu.2020.605644","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2025.08.005","article-title":"Metabolic hallmarks of type 2 diabetes compromise T cell function","author":"Liang Y","year":"2025","unstructured":"Liang Y, Chen W, Gao Q, Tan KC, Lee CH, Ling GS. Metabolic hallmarks of type 2 diabetes compromise T cell function. Trends Endocrinol Metab. 2025, 10.1016\/j.tem.2025.08.005","journal-title":"Trends Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72042","article-title":"Unmasking Tinea incognito: case study, insights into the pathogenesis, and recommendations","volume":"16","author":"Gallegos Espadas D","year":"2024","unstructured":"Gallegos Espadas D, Mart\u00ednez-Ortega JI, Garcia Hernandez DA, S\u00e1nchez Mendieta CP, Fern\u00e1ndez-Reyna I. Unmasking Tinea incognito: case study, insights into the pathogenesis, and recommendations. Cureus. 2024, 16:e72042. 10.7759\/cureus.72042","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73429","article-title":"Malassezia folliculitis: pathogenesis and diagnostic challenges","volume":"16","author":"Mart\u00ednez-Ortega JI","year":"2024","unstructured":"Mart\u00ednez-Ortega JI, Mut Quej JE, Franco Gonz\u00e1lez S. Malassezia folliculitis: pathogenesis and diagnostic challenges. Cureus. 2024, 16:e73429. 10.7759\/cureus.73429","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.02.002","article-title":"The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation","volume":"25","author":"Sparber F","year":"2019","unstructured":"Sparber F, De Gregorio C, Steckholzer S, et al.. The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe. 2019, 25:389-403.e6. 10.1016\/j.chom.2019.02.002","journal-title":"Cell Host Microbe"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114364","article-title":"Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skin","volume":"43","author":"Lee JE","year":"2024","unstructured":"Lee JE, Kim M, Ochiai S, et al.. Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skin. Cell Rep. 2024, 43:114364. 10.1016\/j.celrep.2024.114364","journal-title":"Cell Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa017","article-title":"Biofilm formation, adherence, and hydrophobicity of M. sympodialis, M. globosa, and M. slooffiae from clinical isolates and normal skinVirulence factors of M. sympodialis, M. globosa and M. slooffiae","volume":"58","author":"Angiolella L","year":"2020","unstructured":"Angiolella L, Rojas F, Mussin J, Greco R, Sosa ML, Zalazar L, Giusiano G. Biofilm formation, adherence, and hydrophobicity of M. sympodialis, M. globosa, and M. slooffiae from clinical isolates and normal skinVirulence factors of M. sympodialis, M. globosa and M. slooffiae. Med Mycol. 2020, 58:1162-8. 10.1093\/mmy\/myaa017","journal-title":"Med Mycol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.1.69","article-title":"Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor","volume":"138","author":"Faergemann J","year":"2002","unstructured":"Faergemann J, Gupta AK, Al Mofadi A, Abanami A, Shareaah AA, Marynissen G. Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol. 2002, 138:69-73. 10.1001\/archderm.138.1.69","journal-title":"Arch Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422915-disseminated-pityriasis-versicolor-associated-with-type-2-diabetes-mellitus-a-clinical-case-with-immunometabolic-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:18:33Z","timestamp":1761391113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422915-disseminated-pityriasis-versicolor-associated-with-type-2-diabetes-mellitus-a-clinical-case-with-immunometabolic-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.95377","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,25]]}}}